Fundraising Fox

Cyrebro

Paris, FR · 5 employees on LinkedIn · 2 known investors

Cyrebro Neurosignals develops a neurotechnology platform using EEG and AI to analyze brain activity in real time, providing digital neuromarkers for healthcare applications and consumer product development. The platform serves healthcare professionals, clinical researchers, and consumer product companies in mental health, neurological treatment, and product optimization.

AI & Machine LearningDigital HealthMedical Devices

Investors · 2

ElaiaParis · $108K – $1.6M
Koch Disruptive TechnologiesreportedSan Francisco

In the news

SOC Infrastructure Firm Cyrebro Raises $40 Million - SecurityWeeksecurityweek.com · Sep 2022Israeli cybersecurity startup Cyrebro raises $40 milliontechloy.com · Sep 2022Cyrebro, a specialist in cloud-based security ops centers, locks down $40M | TechCrunchtechcrunch.com · Sep 2022SOC Platform Provider Cyrebro Adds $40M, Eyes MSSP Partner Growth - | news | MSSP Alertmsspalert.com · Sep 2022Cyrebro Raises $40M in Series C Fundingfinsmes.com · Sep 2022Cyrebro raises $15M to expand its security operations platform | VentureBeatventurebeat.com · Apr 2021

Frequently asked questions

What does Cyrebro do?
Cyrebro Neurosignals develops a neurotechnology platform using EEG and AI to analyze brain activity in real time, providing digital neuromarkers for healthcare applications and consumer product development. The platform serves healthcare professionals, clinical researchers, and consumer product companies in mental health, neurological treatment, and product optimization.
Who are Cyrebro's investors?
Cyrebro's investors include Elaia, Koch Disruptive Technologies.
Where is Cyrebro headquartered?
Cyrebro is headquartered in Paris, FR.